why choose us

First received: March 24, 2023

Clinical Trial: A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Multicenter, Dose-Escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 in Patients With Advanced or Metastatic Prostate Cancer

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary activity of RO7656594 in participants with advanced or metastatic prostate cancer.It will also identify recommended doses and regimens for RO7656594 for subsequent studies.

Read more